Mariner, LLC Galectin Therapeutics Inc Transaction History
Mariner, LLC
- $58.4 Billion
- Q4 2024
A detailed history of Mariner, LLC transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Mariner, LLC holds 27,327 shares of GALT stock, worth $35,798. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,327
Previous 26,585
2.79%
Holding current value
$35,798
Previous $73,000
56.16%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding GALT
# of Institutions
98Shares Held
9.82MCall Options Held
1.16MPut Options Held
3.28M-
Vanguard Group Inc Valley Forge, PA2.14MShares$2.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$2.05 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.18MShares$1.55 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA871KShares$1.14 Million0.0% of portfolio
-
Wealthspire Advisors, LLC New York, NY398KShares$521,8690.0% of portfolio
About GALECTIN THERAPEUTICS INC
- Ticker GALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,426,000
- Market Cap $77.8M
- Description
- Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...